Amer Samad is Director at NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK). They have made 1 open-market trade across 1 company since 2017, most recently 2017-07-20.
CIK 0001606579
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $472 since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OSOK | 15,728 | — |
Shares reported on the most recent Form 4, priced at the 2017-08-07 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OSOK | BUY | 2017-05-19 | 2017-07-14 | $0.03 | $472 | N/A | N/A | N/A |